271 related articles for article (PubMed ID: 27929529)
1. Utility of a precursor-to-product ratio in the evaluation of presumptive positives in newborn screening of congenital adrenal hyperplasia.
Tieh PY; Yee JK; Hicks RA; Mao CS; Lee WN
J Perinatol; 2017 Mar; 37(3):283-287. PubMed ID: 27929529
[TBL] [Abstract][Full Text] [Related]
2. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
Janzen N; Peter M; Sander S; Steuerwald U; Terhardt M; Holtkamp U; Sander J
J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
[TBL] [Abstract][Full Text] [Related]
3. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.
Allen DB; Hoffman GL; Fitzpatrick P; Laessig R; Maby S; Slyper A
J Pediatr; 1997 Jan; 130(1):128-33. PubMed ID: 9003862
[TBL] [Abstract][Full Text] [Related]
4. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
[TBL] [Abstract][Full Text] [Related]
5. Neonatal screening: identification of children with 11β-hydroxylase deficiency by second-tier testing.
Janzen N; Riepe FG; Peter M; Sander S; Steuerwald U; Korsch E; Krull F; Müller HL; Heger S; Brack C; Sander J
Horm Res Paediatr; 2012; 77(3):195-9. PubMed ID: 22508345
[TBL] [Abstract][Full Text] [Related]
6. Second-tier Testing for 21-Hydroxylase Deficiency in the Netherlands: A Newborn Screening Pilot Study.
Stroek K; Ruiter A; van der Linde A; Ackermans M; Bouva MJ; Engel H; Jakobs B; Kemper EA; van den Akker ELT; van Albada ME; Bocca G; Finken MJJ; Hannema SE; Mieke Houdijk ECA; van der Kamp HJ; van Tellingen V; Paul van Trotsenburg AS; Zwaveling-Soonawala N; Bosch AM; de Jonge R; Heijboer AC; Claahsen-van der Grinten HL; Boelen A
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4487-e4496. PubMed ID: 34171085
[TBL] [Abstract][Full Text] [Related]
7. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M
Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
[TBL] [Abstract][Full Text] [Related]
8. Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
Lee JE; Moon Y; Lee MH; Jun YH; Oh KI; Choi JW
Ann Clin Lab Sci; 2008; 38(3):235-40. PubMed ID: 18715851
[TBL] [Abstract][Full Text] [Related]
9. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.
Nordenström A; Wedell A; Hagenfeldt L; Marcus C; Larsson A
Pediatrics; 2001 Oct; 108(4):E68. PubMed ID: 11581476
[TBL] [Abstract][Full Text] [Related]
10. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
[TBL] [Abstract][Full Text] [Related]
11. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
Varness TS; Allen DB; Hoffman GL
J Pediatr; 2005 Oct; 147(4):493-8. PubMed ID: 16227036
[TBL] [Abstract][Full Text] [Related]
12. The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns.
Pearce M; Dauerer E; DiRienzo AG; Caggana M; Tavakoli NP
Eur J Pediatr; 2017 Jan; 176(1):121-129. PubMed ID: 27900477
[TBL] [Abstract][Full Text] [Related]
13. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
Hird BE; Tetlow L; Tobi S; Patel L; Clayton PE
Arch Dis Child; 2014 Feb; 99(2):158-64. PubMed ID: 24225272
[TBL] [Abstract][Full Text] [Related]
14. High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening.
Castro PS; Rassi TO; Araujo RF; Pezzuti IL; Rodrigues AS; Bachega TASS; Silva IN
J Pediatr Endocrinol Metab; 2019 May; 32(5):499-504. PubMed ID: 31028712
[TBL] [Abstract][Full Text] [Related]
15. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants.
Güran T; Tezel B; Gürbüz F; Selver Eklioğlu B; Hatipoğlu N; Kara C; Şimşek E; Çizmecioğlu FM; Ozon A; Baş F; Aydın M; Darendeliler F
J Clin Res Pediatr Endocrinol; 2019 Feb; 11(1):13-23. PubMed ID: 30111524
[TBL] [Abstract][Full Text] [Related]
16. [Reevaluation of recalled infants by neonatal mass screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Diagnostic value of pregnanetriolone in a single urine specimen using glass capillary gas chromatography].
Hikita Y
Nihon Naibunpi Gakkai Zasshi; 1985 Mar; 61(3):197-219. PubMed ID: 3874793
[TBL] [Abstract][Full Text] [Related]
17. Cortisol in dried blood screening specimens from newborns with raised 17-hydroxyprogesterone and congenital adrenal hyperplasia.
Mitchell ML; Hermos RJ
Clin Endocrinol (Oxf); 1998 Jun; 48(6):757-60. PubMed ID: 9713565
[TBL] [Abstract][Full Text] [Related]
18. Functional glucocorticoid receptor gene variants do not underlie the high variability of 17-hydroxyprogesterone screening values in healthy newborns.
Schreiner F; Tozakidou M; Maslak R; Holtkamp U; Peter M; Gohlke B; Woelfle J
Eur J Endocrinol; 2009 Apr; 160(4):667-73. PubMed ID: 19174530
[TBL] [Abstract][Full Text] [Related]
19. Outcome of Newborn Screening for Congenital Adrenal Hyperplasia at Two Time Points.
Eshragh N; Doan LV; Connelly KJ; Denniston S; Willis S; LaFranchi SH
Horm Res Paediatr; 2020; 93(2):128-136. PubMed ID: 32659761
[TBL] [Abstract][Full Text] [Related]
20. Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia.
Gatelais F; Berthelot J; Beringue F; Descamps P; Bonneau D; Limal JM; Coutant R
Pediatr Res; 2004 Nov; 56(5):701-5. PubMed ID: 15371568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]